OpenVSafe by OpenVAERS
Search V-safe

3FW-54446-84437

2 vaccinations 2 coded responses 11 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
16-20
ZIP prefix
125 / NY
Registered
2021-09-03
Relationship
Child or adolescent in my care
Guardian
3KU-32084-14469
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-08-13
    Dose 1 — Pfizer-BioNTech
  2. 2021-09-03
    Registered in v-safe
  3. 2021-09-03
    Dose 2 — Pfizer-BioNTech
  4. 2021-09-03
    Health check-in — day 0, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-09-04
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  6. 2021-09-06
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Headache, Nausea
    Adult check-in
  7. 2021-09-07
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-09-10
    Health check-in — day 7, dose 2, dependent
    Feeling: Fair · Fatigue or tiredness, Nausea
    Adult check-in
  9. 2021-09-19
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  10. 2021-09-26
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  11. 2021-10-03
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  12. 2021-10-17
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  13. 2021-12-05
    Survey response — 3 months, dose 2, dependent
    MedDRA: Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Upper respiratory infection
    MedDRA releases: 2024-11 · check-in free text available
  14. 2021-12-05
    Report sent to call center — 3 months, dose 2, dependent
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  15. 2021-12-07
    Call successful
    Participant prefers to complete VAERS report online
  16. 2022-09-03
    Survey response — 12 months, dose 2, dependent
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: COVID
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-08-13Pfizer-BioNTech No
22021-09-03Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-12-05 Successful
2021-12-07
 Participant prefers to complete VAERS report online

Free text

Release 10 — 3 months, dose 2, dependent

2021-12-05

Symptoms: Upper respiratory infection

Release 12 — 12 months, dose 2, dependent

2022-09-03

Symptoms: COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDUpper respiratory tract infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…